Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-16-026082
Filing Date
2016-08-02
Accepted
2016-08-02 12:22:13
Documents
2
Period of Report
2016-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5409
2 EX-24 DOCUMENT attachment1.htm EX-24 6363
  Complete submission text file 0000899243-16-026082.txt   14067
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Issuer) CIK: 0001267813 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 285 RIVERSIDE AVE STE 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVE STE 250 WESTPORT CT 06880 203-855-0400
Canaan VII LP (Reporting) CIK: 0001327625 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 161799624

Mailing Address 285 RIVERSIDE AVENUE STE. 250 WESTPORT CT 06880
Business Address 285 RIVERSIDE AVENUE STE. 250 WESTPORT CT 06880 2038550400
Canaan Partners VII LLC (Reporting) CIK: 0001514133 (see all company filings)

State of Incorp.: CT | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36576 | Film No.: 161799623